- Tumors1000+
- Pathologic Processes985
- Nervous System Diseases905
- Pathology789
- Mental Disorders736
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes985
- Nervous System Diseases905
- Pathology789
- Mental Disorders736
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- ER positive
- PD-L1 positive
- HER2 positive
- KRAS positive
- EGFR negative
- EGFR positive
- PR positive
- BRAF positive
- ALK negative
- ER negative
- PR negative
- PD-L1 negative
- CD20 positive
- BRAF negative
- BRCA1 positive
- IDH positive
- BRCA2 positive
- ALK positive
- HLA positive
- ROS1 negative
- p16 positive
- TP53 positive
- HLA-A positive
- HR positive
- ROS1 positive
- CD19 positive
- PIK3CA positive
- IDH negative
- MET positive
- MYC positive
- NF1 positive
- RET positive
- dMMR positive
- KRAS negative
- MSI-H positive
- NRAS positive
- NTRK positive
- PALB2 positive
- anti-dsDNA positive
- ANA positive
- MET negative
- MSS positive
- RAS positive
- p16 negative
- HBsAg positive
- HPV negative
- HPV positive
- RET negative
- pMMR positive
- ABCA4 positive
- BCL2 positive
- BCR-ABL1 positive
- CCND1 positive
- CFTR positive
- NTRK negative
- RAS negative
- RB1 positive
- TP53 negative
- anti-Sm positive
- ctDNA positive
- BCL6 positive
- BRCA1 negative
- BRCA2 negative
- CD123 positive
- COL7A1 positive
- DMD positive
- HLA negative
- HLA-A negative
- PTEN positive
- RB1 negative
- AKT negative
- APP positive
- BRCA positive
- CD30 positive
- DLL3 positive
- FLT3 positive
- FMR1 positive
- HR negative
- HRAS positive
- MDM2 positive
- MGMT negative
- MGMT positive
- MMR negative
- MSI-H negative
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- PTCH1 positive
- Philadelphia chromosome positive
- PiZZ positive
- RF positive
- RHO positive
- SMARCA4 positive
- TROP2 negative
- TROP2 positive
- dMMR negative
- AKT positive
- ALPL positive
- APOL1 positive
- ARID1A positive
- ATM positive
- Anti-PLA2R positive
- Aβ1-42 positive
- B7-H3 positive
- C5 positive
- CAG repeat in HTT positive
- CD5 positive
- CLDN18.2 positive
- EBV DNA positive
- EBV positive
- FGFR2 positive
- FOXO1 fusion negative
- GPC3 positive
- GRN positive
- HBV DNA negative
- HBsAg negative
- HEXA positive
- HEXB positive
- HPV16 positive
- JAK2 positive
- KIT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- MSS negative
- MUC1 positive
- NF2 positive
- NPM1 positive
- NTRK1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CD positive
- PIK3R1 positive
- PMM2 positive
- PMS2 positive
- PTEN negative
- Ph positive
- SMARCB1 negative
- SPINK5 positive
- T790M positive
- TET2 positive
- TTR positive
- UBA1 positive
- UGT1A1 positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Smith positive
- t(11;14) positive
- 11q negative
- 11q positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT1 E17K positive
- AKT1 positive
- ALT positive
- APC positive
- APOE e4 positive
- ASXL1 positive
- ATA positive
- ATN1 positive
- ATXN2 positive
- Acetylcholine receptor antibody positive
- Anti-CCP-2 positive
- Anti-HBc IgM negative
- Anti-HMGCR positive
- Anti-Ro/SS-A positive
- Anti-SSA (Ro) positive
- Anti-SSB (La) positive
- Anti-Smith antibodies positive
- Antinuclear antibody positive
- Aβ1-40 positive
- Aβ1-42/Aβ1-40 ratio positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Biologic Anti-Neoplastic Agent
- CD4+ > 350 cells/microliter for at least twelve months
- Cancer-Directed Surgery
- Cellular Therapies for ALS
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
5982 trials
1
2
3
…50